| __timestamp | Novo Nordisk A/S | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 26760000000 | 1213000 |
| Thursday, January 1, 2015 | 32169000000 | 3425000 |
| Friday, January 1, 2016 | 32339000000 | 6311000 |
| Sunday, January 1, 2017 | 32124000000 | 9518000 |
| Monday, January 1, 2018 | 33313000000 | 28080000 |
| Tuesday, January 1, 2019 | 35830000000 | 36550000 |
| Wednesday, January 1, 2020 | 36886000000 | 46125000 |
| Friday, January 1, 2021 | 41058000000 | 68486000 |
| Saturday, January 1, 2022 | 50684000000 | 92032000 |
| Sunday, January 1, 2023 | 61598000000 | 117532000 |
| Monday, January 1, 2024 | 67377000000 |
Unleashing the power of data
In the world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability and growth. This chart provides a fascinating comparison between Novo Nordisk A/S and Rhythm Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Novo Nordisk's SG&A expenses have surged by approximately 130%, reflecting its expansive global operations and marketing efforts. In contrast, Rhythm Pharmaceuticals, a smaller player, has seen its SG&A expenses grow by nearly 9,600%, indicative of its aggressive market entry and expansion strategies.
Novo Nordisk, a Danish multinational, has consistently maintained a robust financial position, with SG&A expenses peaking at around 61.6 billion in 2023. Meanwhile, Rhythm Pharmaceuticals, based in the U.S., has steadily increased its spending, reaching approximately 117.5 million in the same year. This stark contrast highlights the diverse strategies and scales of operation within the pharmaceutical industry.
Novo Nordisk A/S or Vertex Pharmaceuticals Incorporated: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Novo Nordisk A/S vs ImmunityBio, Inc. Trends and Insights
Breaking Down SG&A Expenses: Novo Nordisk A/S vs Soleno Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Novo Nordisk A/S or MannKind Corporation
SG&A Efficiency Analysis: Comparing Novo Nordisk A/S and HUTCHMED (China) Limited
Biogen Inc. and Rhythm Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Rhythm Pharmaceuticals, Inc.
Dr. Reddy's Laboratories Limited or Rhythm Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Rhythm Pharmaceuticals, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for ADMA Biologics, Inc. and Rhythm Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Rhythm Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.
Rhythm Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.: SG&A Spending Patterns Compared